Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin

被引:42
作者
Fiorucci, S
Distrutti, E
Mencarelli, A
Morelli, A
Laufer, SA
Cirino, G
Wallace, JL
机构
[1] Univ Perugia, Clin Gastroenterol & Epatol, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy
[2] Univ Tubingen, Dept Pharmaceut & Med Chem, Inst Pharm, Tubingen, Germany
[3] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy
[4] Univ Calgary, Dept Pharmacol, Calgary, AB T2N 1N4, Canada
关键词
leukotriene B4; lipoxin; aspirin-triggered lipoxin; neutrophils/endothelium adherence; aspirin; 5-lipoxigenase; cyclooxygenase; celcoxib; rofecoxib;
D O I
10.1038/sj.bjp.0705356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Unlike other nonsteroidal anti-inflammatory drugs that inhibit formation of cyclooxygenase (COX)-dependent eicosanoids, acetylation of COX-2 by aspirin switches eicosanoid biosynthesis from prostaglandin E-2 (PGE(2)) to 15-epi-lipoxin A(4) (15-epi-LXA(4) or aspirin-triggered lipoxin, ATL). ATL formation by activated leukocytes (PMN) requires the intervention of 5-lipoxygenase (5-LOX), an enzyme that is involved in leukotriene B-4 (LTB4) formation. 2 In the present study, we have examined the role of acetylated COX-2 and 5-LOX in modulating antiadhesive effects of aspirin on adhesion of PMN to endotoxin (LPS)-primed human umbilical endothelial cells ( HUVEC). 3 Treating PMN/HUVEC cocultures with aspirin resulted in a concentration-dependent inhibition of cell-to-cell adhesion induced by LPS. Treating HUVEC with selective COX-2 inhibitors, celecoxib and rofecoxib, caused an approximate to70% reversion of antiadhesive effect of aspirin. In contrast, inhibition of neutrophil's 5-LOX pathway with 1 muM ZD2138, a selective 5-LOX inhibitor, 1 muM BAY-X-1005, a FLAP inhibitor, or 100 muM licofelone, a dual COX/5-LOX inhibitor, did not affect antiadhesive properties of aspirin. 4 Exposure to celecoxib (100 muM) or rofecoxib (10 muM) completely suppressed ATL formation caused by aspirin without affecting LTB4 levels. ZD2138, licofelone and BAY-X-1005 inhibited ATL formation as well as LTB4 generation. 5 Treatment with LXA(4) reduced PMN adhesion to HUVEC and counteracted the proadhesive effect of celecoxib. In contrast, exposure to Boc-1, an LXA(4) antagonist, counteracts the antiadhesive activities of aspirin. Exposure to U75302, an LTB4 receptor antagonist, enhances the antiadesive effect of aspirin. 6 Reversal of antiadhesive activities of aspirin by celecoxib was associated with increased expression of LFA-1 on PMN and E-selectin on HUVEC. Addition of LXA(4), ZD2138 and U75302 inhibited these changes. 7 The present results support the notion that inhibition of ATL formation is mechanistically linked to the reversal of the antiadhesive activity of aspirin caused by selective COX-1 inhibitors and suggests that the LTB4/ATL balance modulates pro- and antiadhesive activity of nonsteroidal antiinflammatory drugs at the leukocyte-endothelial cell interface.
引用
收藏
页码:1351 / 1359
页数:9
相关论文
共 34 条
[31]  
Smith WG, 1995, J PHARMACOL EXP THER, V275, P1332
[32]   Aspirin-triggered 15-epi-lipoxin A(4) (LXA(4)) and LXA(4) stable analogues are potent inhibitors of Acute inflammation: Evidence for anti-inflammatory receptors [J].
Takano, T ;
Fiore, S ;
Maddox, JF ;
Brady, HR ;
Petasis, NA ;
Serhan, CN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1693-1704
[33]   Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues [J].
Takano, T ;
Clish, CB ;
Gronert, K ;
Petasis, N ;
Serhan, CN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :819-826
[34]   Leukotriene B4 receptor -: Cloning and intracellular signaling [J].
Yokomizo, T ;
Masuda, K ;
Kato, K ;
Toda, A ;
Izumi, T ;
Shimizu, T .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) :S51-S55